(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are SOC FRANC CASINOS, SODITECH, and KITRON.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| SOC FRANC CASINOS (SFCA.PA) | 2.10 | 17.32% | 2023-04-28 11:04:19 |
| SODITECH (SEC.PA) | 1.67 | 14.38% | 2023-04-28 11:04:34 |
| KITRON (KIT.OL) | 40.15 | 13.1% | 2023-04-28 08:30:51 |
| ENSURGE MICROPOWER (ENSU.OL) | 0.16 | 11.39% | 2023-04-28 08:22:11 |
| BIOSENIC (BIOS.BR) | 0.10 | 11.36% | 2023-04-28 11:06:43 |
| TOYOTA CAETANO (SCT.LS) | 4.50 | 10.84% | 2023-04-28 11:19:55 |
| OCEANTEAM (OTS.OL) | 1.55 | 9.54% | 2023-04-28 11:32:15 |
| MEDISTIM (MEDI.OL) | 272.00 | 8.37% | 2023-04-28 11:31:23 |
| WILSON (WILS.OL) | 66.60 | 7.42% | 2023-04-28 11:35:40 |
| BELIEVE (BLV.PA) | 10.40 | 7.22% | 2023-04-28 11:45:16 |
The three biggest losers today are SOLOCAL GROUP, LECTRA, and REMY COINTREAU.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| SOLOCAL GROUP (LOCAL.PA) | 0.23 | -22.13% | 2023-04-28 08:03:27 |
| LECTRA (LSS.PA) | 28.75 | -12.88% | 2023-04-28 11:52:23 |
| REMY COINTREAU (RCO.PA) | 160.00 | -10.06% | 2023-04-28 11:02:41 |
| OSE IMMUNO (OSE.PA) | 4.03 | -9.64% | 2023-04-28 11:01:33 |
| FONCIERE EURIS (EURS.PA) | 2.26 | -9.6% | 2023-04-28 08:49:23 |
| SANOFI NV23 (SANNV.PA) | 98.00 | -9.26% | 2023-04-28 11:03:23 |
| AUTOSTORE HOLDINGS (AUTO.OL) | 22.72 | -9.12% | 2023-04-28 11:21:03 |
| REINET INVESTMENTS (REINA.AS) | 19.50 | -8.88% | 2023-04-28 11:04:46 |
| DIAGEO (DGE.PA) | 41.20 | -8.44% | 2023-04-28 11:47:50 |
| TF1 (TFI.PA) | 7.22 | -8.32% | 2023-04-28 11:05:38 |
Winners today
1. SOC FRANC CASINOS (SFCA.PA)
17.32% Price Change
Société Française de Casinos Société Anonyme operates casinos in France. The company is also involved in the hotel and restaurant activities. The company is based in Paris, France.
CAC 40 ended the session with SOC FRANC CASINOS jumping 17.32% to €2.10 on Friday, after five consecutive sessions in a row of losses. CAC 40 rose 0.1% to €7,491.50, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, SOC FRANC CASINOS has a trailing twelve months EPS of €0.3.
PE Ratio
SOC FRANC CASINOS has a trailing twelve months price to earnings ratio of 7. Meaning, the purchaser of the share is investing €7 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.61%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SOC FRANC CASINOS’s stock is considered to be overbought (>=80).
Yearly Top and Bottom Value
SOC FRANC CASINOS’s stock is valued at €2.10 at 22:40 EST, higher than its 52-week high of €2.02.
Volatility
SOC FRANC CASINOS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 11.73%, a negative 0.60%, and a positive 7.62%.
SOC FRANC CASINOS’s highest amplitude of average volatility was 11.73% (last week), 7.90% (last month), and 7.62% (last quarter).
Moving Average
SOC FRANC CASINOS’s worth is way above its 50-day moving average of €1.83 and way above its 200-day moving average of €1.72.
More news about SOC FRANC CASINOS.
2. SODITECH (SEC.PA)
14.38% Price Change
Soditech SA engages in the integration of mechanical, thermal, and electronic sub-assemblies in space, research, and defense fields in France. It designs structural sub-assemblies and integrates optical and thermal equipment, such as OSRs, SSMs, heaters, and heat pipes; designs and manufactures multi-layer insulation products; and designs, manufactures, and tests space harnesses on instruments or platforms. The company also provides calculation services, such as static, dynamic, thermal, and thermoelastic; designs assembly tools; and designs and produces super insulating multi-layer mattresses for ultra-vacuum areas. In addition, it develops, qualifies, manufactures, and tests embedded cabinets; and designs, assembles, and tests racks and test equipment racks. The company was formerly known as Soditech Ingenierie SA. Soditech SA was founded in 1990 and is headquartered in Aix-en-Provence, France.
CAC 40 ended the session with SODITECH rising 14.38% to €1.67 on Friday, after four sequential sessions in a row of losses. CAC 40 rose 0.1% to €7,491.50, following the last session’s upward trend on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, SODITECH has a trailing twelve months EPS of €0.34.
PE Ratio
SODITECH has a trailing twelve months price to earnings ratio of 4.91. Meaning, the purchaser of the share is investing €4.91 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.66%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SODITECH’s stock is considered to be overbought (>=80).
Moving Average
SODITECH’s worth is way higher than its 50-day moving average of €1.51 and way higher than its 200-day moving average of €1.42.
Volatility
SODITECH’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.37%, a positive 1.04%, and a positive 8.76%.
SODITECH’s highest amplitude of average volatility was 6.37% (last week), 13.26% (last month), and 8.76% (last quarter).
Volume
Today’s last reported volume for SODITECH is 2000 which is 181.29% above its average volume of 711.
More news about SODITECH.
3. KITRON (KIT.OL)
13.1% Price Change
Kitron ASA operates as an electronics manufacturing services company in Norway, Sweden, rest of Europe, the United States, and internationally. It manufactures electronics that are embedded in the customers' products; and box-built electronic products. The company's services include development services, such as product development, product management, and re-engineering services; and industrialization services, including prototype manufacturing, evaluation of new products, component engineering and database, test development, design and build of high level assembly lines, and environmental durability testing. Its services also comprise sourcing and procurement services; manufacturing, assembling, and testing of electronic products for the professional market; redesign, repair, and maintenance; and logistics and distribution services. The company was incorporated in 1996 and is headquartered in Billingstad, Norway.
Oslo Børs Benchmark Index_GI ended the session with KITRON rising 13.1% to €40.15 on Friday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 1.09% to €1,226.44, after two sequential sessions in a row of gains, on what was an all-around positive trend trading session today.
Earnings Per Share
As for profitability, KITRON has a trailing twelve months EPS of kr1.4.
PE Ratio
KITRON has a trailing twelve months price to earnings ratio of 28.68. Meaning, the purchaser of the share is investing kr28.68 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21%.
Volatility
KITRON’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.03%, a positive 0.17%, and a positive 1.88%.
KITRON’s highest amplitude of average volatility was 2.27% (last week), 1.79% (last month), and 1.88% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 59.1% and 54.5%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
KITRON’s EBITDA is 39.74.
More news about KITRON.
4. ENSURGE MICROPOWER (ENSU.OL)
11.39% Price Change
Ensurge Micropower ASA designs, develops, and produces ultrathin energy storage solutions for wearable devices, connected sensors, and other applications. Its solid-state lithium battery technology enables it to produce rechargeable batteries with high energy densities. The company was formerly known as Thin Film Electronics ASA and changed its name to Ensurge Micropower ASA in June 2021. Ensurge Micropower ASA was incorporated in 2005 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with ENSURGE MICROPOWER jumping 11.39% to €0.16 on Friday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 1.09% to €1,226.44, after two consecutive sessions in a row of gains, on what was an all-around positive trend exchanging session today.
Earnings Per Share
As for profitability, ENSURGE MICROPOWER has a trailing twelve months EPS of kr-0.58.
Volume
Today’s last reported volume for ENSURGE MICROPOWER is 14157000 which is 129.09% above its average volume of 6179610.
More news about ENSURGE MICROPOWER.
5. BIOSENIC (BIOS.BR)
11.36% Price Change
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.
BEL 20 ended the session with BIOSENIC jumping 11.36% to €0.10 on Friday, after five successive sessions in a row of losses. BEL 20 rose 0.59% to €3,801.81, after three successive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, BIOSENIC has a trailing twelve months EPS of €-0.34.
Volume
Today’s last reported volume for BIOSENIC is 309625 which is 2.25% below its average volume of 316765.
More news about BIOSENIC.
6. TOYOTA CAETANO (SCT.LS)
10.84% Price Change
Toyota Caetano Portugal, S.A. imports, assembles, and commercializes light and heavy vehicles. It offers commercial and passenger cars, as well as parts; cargo handling machines; and mini-buses. The company also sells and rents industrial equipment, including forklifts; sells vehicle parts; provides technical and after-sales assistance; and incorporates components in commercial vehicles. It distributes its products under the Toyota and Lexus brand names in Portugal, Belgium, African countries, Spain, Germany, the United Kingdom, and internationally. The company was incorporated in 1946 and is headquartered in Vila Nova de Gaia, Portugal. Toyota Caetano Portugal, S.A. is a subsidiary of Salvador Caetano Auto (S.G.P.S.), S.A.
PSI ended the session with TOYOTA CAETANO rising 10.84% to €4.50 on Friday, after four consecutive sessions in a row of losses. PSI slid 0.51% to €6,212.33, after two sequential sessions in a row of gains, on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, TOYOTA CAETANO has a trailing twelve months EPS of €0.46.
PE Ratio
TOYOTA CAETANO has a trailing twelve months price to earnings ratio of 9.78. Meaning, the purchaser of the share is investing €9.78 for every euro of annual earnings.
More news about TOYOTA CAETANO.
7. OCEANTEAM (OTS.OL)
9.54% Price Change
Oceanteam ASA operates as a subsea and offshore services company in Europe. It provides equipment for offshore cable laying, umbilical installations, handling of subsea cables, and on- and offshore storage and transport. The company also rents turntables, tensioners, reels, demountable carousels, and other cable handling equipment. It serves renewable, and oil and gas industries. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Bærum, Norway.
Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM rising 9.54% to €1.55 on Friday while Oslo Børs Benchmark Index_GI rose 1.09% to €1,226.44.
Earnings Per Share
As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.46.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.42%.
Moving Average
OCEANTEAM’s value is above its 50-day moving average of kr1.44 and way under its 200-day moving average of kr1.97.
More news about OCEANTEAM.
8. MEDISTIM (MEDI.OL)
8.37% Price Change
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with MEDISTIM jumping 8.37% to €272.00 on Friday, after three successive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 1.09% to €1,226.44, after two successive sessions in a row of gains, on what was an all-around up trend trading session today.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr5.63.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 48.31. Meaning, the purchaser of the share is investing kr48.31 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.83%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MEDISTIM’s EBITDA is 124.96.
Sales Growth
MEDISTIM’s sales growth is 26% for the current quarter and 10.2% for the next.
Volume
Today’s last reported volume for MEDISTIM is 1708 which is 83.69% below its average volume of 10474.
Moving Average
MEDISTIM’s value is higher than its 50-day moving average of kr250.35 and way above its 200-day moving average of kr244.21.
More news about MEDISTIM.
9. WILSON (WILS.OL)
7.42% Price Change
Wilson ASA operates as a shipping company in Europe. The company engages in the ship chartering and operation; ship management; marine accounting; crewing; purchasing; legal; and insurance activities. It operates through a fleet of 130 vessels in the range of 1500 to 8500 DWT. The company was founded in 1929 and is headquartered in Bergen, Norway. Wilson ASA operates as a subsidiary of Caiano AS.
Oslo Børs Benchmark Index_GI ended the session with WILSON rising 7.42% to €66.60 on Friday, after two successive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 1.09% to €1,226.44, after two sequential sessions in a row of gains, on what was an all-around up trend exchanging session today.
Earnings Per Share
As for profitability, WILSON has a trailing twelve months EPS of kr21.12.
PE Ratio
WILSON has a trailing twelve months price to earnings ratio of 3.15. Meaning, the purchaser of the share is investing kr3.15 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 44.99%.
Moving Average
WILSON’s value is under its 50-day moving average of kr68.45 and above its 200-day moving average of kr66.56.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Nov 14, 2022, the estimated forward annual dividend rate is 9 and the estimated forward annual dividend yield is 13.2%.
More news about WILSON.
10. BELIEVE (BLV.PA)
7.22% Price Change
Believe S.A. provides music distribution and marketing services for artists and labels worldwide. The company's physical and digital distribution services include a range of digital music services and video streaming, as well as a network of physical distribution partners. It also provides trade marketing, video, sync, and additional services; and technology and analytics for clients to manage and promote their catalog. Believe S.A. was incorporated in 2005 and is headquartered in Paris, France.
CAC 40 ended the session with BELIEVE rising 7.22% to €10.40 on Friday while CAC 40 rose 0.1% to €7,491.50.
Earnings Per Share
As for profitability, BELIEVE has a trailing twelve months EPS of €-0.18.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.32%.
More news about BELIEVE.
Losers Today
1. SOLOCAL GROUP (LOCAL.PA)
-22.13% Price Change
Solocal Group S.A. provides digital services in France and internationally. Its services include connect that allows VSEs and SMEs to manage their digital presence on PagesJaunes and various Web through mobile application, or a web interface, as well as manages interactions between professionals and their customers; and booster that allows companies to increase their digital visibility in the Web. The company was formerly known as PagesJaunes Groupe and changed its name to SoLocal Group S.A. in June 2013. Solocal Group S.A. was founded in 1896 and is based in Boulogne-Billancourt, France.
CAC 40 ended the session with SOLOCAL GROUP sliding 22.13% to €0.23 on Friday, after five successive sessions in a row of losses. CAC 40 jumped 0.1% to €7,491.50, following the last session’s upward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, SOLOCAL GROUP has a trailing twelve months EPS of €0.17.
PE Ratio
SOLOCAL GROUP has a trailing twelve months price to earnings ratio of 1.38. Meaning, the purchaser of the share is investing €1.38 for every euro of annual earnings.
Revenue Growth
Year-on-year quarterly revenue growth declined by 6.2%, now sitting on 414.64M for the twelve trailing months.
More news about SOLOCAL GROUP.
2. LECTRA (LSS.PA)
-12.88% Price Change
Lectra SA designs smart industrial solutions for fashion, automotive, and furniture markets. The company's solutions include software, automated cutting equipment, and related services, which enable customers to automate and optimize product design, development, and manufacture of garments, car seats and interiors, airbags, and sofas, as well as to digitalize their processes. It also offers technical maintenance, support, training, and consulting services; and sells consumables and parts. The company operates in Europe, the Americas, the Asia-Pacific, and internationally. Lectra SA was founded in 1973 and is headquartered in Paris, France.
CAC 40 ended the session with LECTRA sliding 12.88% to €28.75 on Friday, after four sequential sessions in a row of losses. CAC 40 rose 0.1% to €7,491.50, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, LECTRA has a trailing twelve months EPS of €1.12.
PE Ratio
LECTRA has a trailing twelve months price to earnings ratio of 25.67. Meaning, the purchaser of the share is investing €25.67 for every euro of annual earnings.
Volume
Today’s last reported volume for LECTRA is 81386 which is 166.23% above its average volume of 30569.
More news about LECTRA.
3. REMY COINTREAU (RCO.PA)
-10.06% Price Change
Rémy Cointreau SA, together with its subsidiaries, engages in the production, sale, and distribution of liqueurs and spirits. The company operates through Rémy Martin, Liqueurs & Spirits, and Partner Brands segments. It offers liqueurs, brandy, gin, single malt whisky, rum, wine, and champagne primarily under the Cointreau, Metaxa, St-Rémy, Mount Gay, Bruichladdich, Port Charlotte, Octomore, The Botanist, Westland, LOUIS XIII, and Domaine des Hautes Glaces brands. The company operates in Europe, the Middle East, Africa, the Americas, Asia, Australia, and New Zealand. Rémy Cointreau SA was founded in 1724 and is headquartered in Cognac, France.
CAC 40 ended the session with REMY COINTREAU sliding 10.06% to €160.00 on Friday while CAC 40 rose 0.1% to €7,491.50.
Earnings Per Share
As for profitability, REMY COINTREAU has a trailing twelve months EPS of €5.8.
PE Ratio
REMY COINTREAU has a trailing twelve months price to earnings ratio of 27.59. Meaning, the purchaser of the share is investing €27.59 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.16%.
Moving Average
REMY COINTREAU’s value is below its 50-day moving average of €168.32 and below its 200-day moving average of €170.78.
More news about REMY COINTREAU.
4. OSE IMMUNO (OSE.PA)
-9.64% Price Change
OSE Immunotherapeutics SA, a clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally. Its products include Tedopi that is in Phase III clinical trial for the treatment of non-small cell lung cancer, as well as in Phase II clinical trial to pancreatic and ovarian cancer; OSE-279, which is in a Phase I/II clinical trial in patients with advanced solid tumors or lymphomas; OSE-127, a humanized monoclonal antibody that is in Phase II clinical trial for the treatment of ulcerative colitis, as well as Sjögren's Syndrome; and FR104, which is in Phase I clinical trial for the treatment of rheumatoid arthritis. The company is also developing BI 765063, which is in Phase I clinical trial to treat solid tumors; OSE-230, an agonist antibody against ChemR23 to resolve chronic inflammation; CLEC-1, a therapeutic target in immune-oncology and identified monoclonal antibody antagonists; and BiCKI, a novel bispecific checkpoint inhibitor platform that targets PD-1 to fight primary and secondary resistance mechanisms developed by cancers. OSE Immunotherapeutics SA has collaborations and partnerships with GERCOR, ARCAGY-GINECO, Foundation FoRT, and Nantes University Hospital; and Boehringer Ingelheim, MabSilico, CKD, Servier, Veloxis Pharmaceuticals, and Chong Kun Dang Pharmaceutical Corporation. The company was formerly known as OSE Pharma SA and changed its name to OSE Immunotherapeutics SA in May 2016. OSE Immunotherapeutics SA was founded in 2012 and is headquartered in Nantes, France.
CAC 40 ended the session with OSE IMMUNO dropping 9.64% to €4.03 on Friday, following the last session’s upward trend. CAC 40 rose 0.1% to €7,491.50, following the last session’s upward trend on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, OSE IMMUNO has a trailing twelve months EPS of €-0.39.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -14.81%.
More news about OSE IMMUNO.
5. FONCIERE EURIS (EURS.PA)
-9.6% Price Change
Foncière Euris SA distributes food and specialized products in France and internationally. The company also owns real estate assets, including shopping centers; and manages commercial real estate properties and private equity portfolio. The company was incorporated in 1970 and is based in Paris, France. Foncière Euris SA operates as a subsidiary of Finatis Société Anonyme.
CAC 40 ended the session with FONCIERE EURIS dropping 9.6% to €2.26 on Friday, after five consecutive sessions in a row of losses. CAC 40 jumped 0.1% to €7,491.50, following the last session’s upward trend on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, FONCIERE EURIS has a trailing twelve months EPS of €-13.65.
Volume
Today’s last reported volume for FONCIERE EURIS is 40 which is 84.31% below its average volume of 255.
More news about FONCIERE EURIS.
6. SANOFI NV23 (SANNV.PA)
-9.26% Price Change
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
CAC 40 ended the session with SANOFI NV23 falling 9.26% to €98.00 on Friday while CAC 40 jumped 0.1% to €7,491.50.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.77%.
Yearly Top and Bottom Value
SANOFI NV23’s stock is valued at €98.00 at 22:40 EST, higher than its 52-week high of €94.88.
More news about SANOFI NV23.
7. AUTOSTORE HOLDINGS (AUTO.OL)
-9.12% Price Change
AutoStore Holdings Ltd., a robotic and software technology company, provides warehouse automation solutions in Norway, rest of Nordics, Germany, rest of Europe, the United States, Asia, and internationally. It offers grids, bins, robots, workstations, controllers, and spare parts. The company also provides warehouse management software. It serves retail, grocery, third party logistic, industrial, and healthcare industries. The company was formerly known as AutoStore NewCo Ltd. and changed its name to AutoStore Holdings Ltd. in October 2021. AutoStore Holdings Ltd. was founded in 1996 and is headquartered in Nedre Vats, Norway.
Oslo Børs Benchmark Index_GI ended the session with AUTOSTORE HOLDINGS falling 9.12% to €22.72 on Friday, after two sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 1.09% to €1,226.44, after two sequential sessions in a row of gains, on what was an all-around up trend exchanging session today.
Earnings Per Share
As for profitability, AUTOSTORE HOLDINGS has a trailing twelve months EPS of kr0.23.
PE Ratio
AUTOSTORE HOLDINGS has a trailing twelve months price to earnings ratio of 98.78. Meaning, the purchaser of the share is investing kr98.78 for every norwegian krone of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AUTOSTORE HOLDINGS’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for AUTOSTORE HOLDINGS is 19505100 which is 806.67% above its average volume of 2151290.
More news about AUTOSTORE HOLDINGS.
8. REINET INVESTMENTS (REINA.AS)
-8.88% Price Change
Reinet Investments S.C.A. operates as a securitization vehicle in Luxembourg. The company, through its subsidiary, Reinet Fund S.C.A., F.I.S., invests in assets. Reinet Investments Manager S.A. operates as a general partner of Reinet Investments S.C.A. The company was formerly known as Richemont S.A. and changed its name to Reinet Investments S.C.A. in October 2008. Reinet Investments S.C.A. was incorporated in 1979 and is based in Luxembourg.
AEX-Index ended the session with REINET INVESTMENTS sliding 8.88% to €19.50 on Friday, following the last session’s upward trend. AEX-Index jumped 0.78% to €758.49, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, REINET INVESTMENTS has a trailing twelve months EPS of €4.44.
PE Ratio
REINET INVESTMENTS has a trailing twelve months price to earnings ratio of 4.39. Meaning, the purchaser of the share is investing €4.39 for every euro of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, REINET INVESTMENTS’s stock is considered to be oversold (<=20).
More news about REINET INVESTMENTS.
9. DIAGEO (DGE.PA)
-8.44% Price Change
Diageo plc, together with its subsidiaries, produces, markets, and sells alcoholic beverages. The company offers scotch, whisky, gin, vodka, rum, ready to drink products, raki, liqueur, wine, tequila, Canadian whisky, American whiskey, cachaca, and brandy, as well as beer, including cider and non-alcoholic products. It provides its products primarily under the Johnnie Walker, Guinness, Tanqueray, Baileys, Smirnoff, Captain Morgan, Crown Royal, Don Julio, Ciroc, Buchanan's, Casamigos, J&B, and Ketel One brands. The company operates in North America, Europe, Turkey, Africa, Latin America, the Caribbean, the Asia Pacific, and internationally. The company was incorporated in 1886 and is headquartered in London, the United Kingdom.
CAC 40 ended the session with DIAGEO dropping 8.44% to €41.20 on Friday, after two successive sessions in a row of gains. CAC 40 jumped 0.1% to €7,491.50, following the last session’s upward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, DIAGEO has a trailing twelve months EPS of €1.77.
PE Ratio
DIAGEO has a trailing twelve months price to earnings ratio of 23.28. Meaning, the purchaser of the share is investing €23.28 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 38.1%.
More news about DIAGEO.
10. TF1 (TFI.PA)
-8.32% Price Change
TF1 SA engages in the broadcasting, studios and entertainment, and digital businesses in France and internationally. The company offers DTT channels, including TMC, TFX, and TF1 Séries Films; Theme channels, such as TV Breizh, Ushuaïa TV, and Histoire TV; e-TF1; websites; and advertising services, as well as TF1, which covers sports, French drama, news, entertainment, sports, and movies. It also operates studios, including Newen Studios; TF1 Studio; and entertainment channel comprising TF1 Entertainment. In addition, the company operates Unify, a digital channel. Further, it offers digital content management, theme channel, content/broadcasting internet and TV, and TV news images agency services, as well as engages in the acquisition/sale of audiovisual rights and e-commerce activities. TF1 SA was incorporated in 1982 and is headquartered in Boulogne-Billancourt, France.
CAC 40 ended the session with TF1 sliding 8.32% to €7.22 on Friday while CAC 40 rose 0.1% to €7,491.50.
Earnings Per Share
As for profitability, TF1 has a trailing twelve months EPS of €0.82.
PE Ratio
TF1 has a trailing twelve months price to earnings ratio of 8.8. Meaning, the purchaser of the share is investing €8.8 for every euro of annual earnings.
Volume
Today’s last reported volume for TF1 is 236019 which is 3.57% above its average volume of 227882.
Volatility
TF1’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.01%, a positive 0.07%, and a positive 1.19%.
TF1’s highest amplitude of average volatility was 1.59% (last week), 1.35% (last month), and 1.19% (last quarter).
More news about TF1.
Stay up to date with our winners and losers daily report
